As immunotherapy revolutionizes lung cancer treatment, scientists are considering how to make it work for more of those affected by the disease.
Survivors facing new medical concerns may fear the unknown, but perseverance is possible as they navigate unexpected challenges in their new normal.
An Extraordinary Healer essay honoring Tabatha Doyle, RN [ St. Jude Children's Research Hospital in Memphis, Tennessee ]
Nancy Carpenter was FreeToBreathe's featured survivor of the month for April.
A world champion figure skater offers his spin on the blessings behind survivorship.
Vassiliki A. Papadimitrakopoulou, M.D., honored at the 19th Annual International Lung Cancer Congress.
To best help the melanoma community, the FDA must not only approve medications, but also focus on cancer prevention.
The three-drug combination of Tagrisso plus platinum-based chemotherapy and pemetrexed boosted outcomes for patients with EGFR-mutant advanced non-small cell lung cancer.
"Dr. Rosenzweig’s commitment to helping patients with lung cancer and mesothelioma is truly heroic," several colleagues write.
To combat the stigma around mental health care for patients with lung cancer, survivor Nancy Cohen shares her own treatment story and why she feels it's important to include mental health care during cancer treatment.
Fifteen years after my own cancer journey, I find myself balancing hope and grief as I support a colleague newly diagnosed with cancer.
Ricardo J. Bello, postdoctoral research fellow at Johns Hopkins School of Medicine, discusses the importance of patient education to drive the decision-making process in breast reconstruction and surgery. With more knowledge, they can ask higher level questions and help the field thrive.
Rick Bulifant shares his bladder cancer story.
One survivor describes her journey with breast implant associated anaplastic large cell lymphoma, and how she advocates for more awareness to protect future patients.
After eight years with no new treatments for ovarian cancer, PARP inhibitors and anti-angiogenics are benefiting patients.
An Extraordinary Healer essay honoring Nicole Guttierrez, RN, CCRC [ East Jefferson General Hospital Cancer Center in Metaire, Louisiana ]
An Extraordinary Healers essay honoring Diane Moore, RN [Children's Medical Center in Dallas, Texas]
Sam Smith, University of Leeds, explains cognitive behavioral therapy for patients with breast cancer.
The Aplastic Anemia & MDS International Foundation presented its first Lifetime Achievement in Science Award to Mary Horowitz, MD, MS at the Foundation’s 35th Anniversary Luncheon and Awards Program on May 18, 2019. Dr. Horowitz was honored for the significant impact her work has had on stem cell transplant and hematologic malignancy practice worldwide.
The landscape for patients with renal cell carcinoma could potentially change as the use of immune checkpoint inhibition shows promise for these patients.
Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for May 2021.
After receiving a diagnosis of medulloblastoma at age 11, one woman has lived decades with the disease as her uninvited companion. Now, she writes, speaks and advocates for others facing cancer.
SOME CANCER TREATMENT CENTERS are mere conveyer belts for infusion.
Recent research found that patients under 50 were less likely to have a treatment-determining biomarker than their older counterparts.
An ovarian cancer survivor uses her art to make her hidden emotional journey visible.
There seems to be a shift in the field of oncology where patients are looking more toward being treated close to home rather than traveling to a large academic treatment center, explained Edward S. Kim, M.D., Chair of the Department of Solid Tumor Oncology at Levine Cancer Institute, at Association of Community Cancer Centers 34th National Oncology Conference.
David Gershenson, M.D., of MD Anderson Cancer Center, explains the difficulty of advancing treatment of rare ovarian cancers: malignant ovarian germ cell tumors, sex cord stromal tumors, and types of epithelial tumors such as ovarian clear cell carcinoma, ovarian low-grade serous carcinoma, and mucinous tumors.